Hsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1.

Published in: Journal of oncology (2021)

This work revealed that miR-330-5p facilitated the TC progression through targeting FOXE1, which may offer novel therapeutic options for TC.

Keyphrases